
Loading, please wait...

Loading, please wait...
"Wherever the art of Medicine is loved, there is also a love of Humanity."
— Hippocrates

Advance care planning MLTC is an essential clinical process that allows patients to document their future care preferences before they lose decision-making capacity. For clinicians, managing patients with multiple chronic illnesses presents unique hurdles compared to single-disease trajectories. Consequently, clinical decline often goes unrecognized because medical responsibility is spread across different specialists. A recent study highlights that fragmented care and diffused ownership frequently delay these vital end-of-life conversations.
Specifically, the complexity of multiple long-term conditions often masks the transition into a terminal phase. Furthermore, professionals note that cumulative illness burden and social adversity contribute significantly to the late recognition of deterioration. Moreover, organizational barriers such as resource constraints and poor information sharing create unclear ownership of the planning process. As a result, patients experiencing socioeconomic inequity face the highest risks of receiving care that does not align with their personal values.
Research suggests that effective advance care planning MLTC should be introduced early in the disease trajectory. Instead of treating it as a one-time event, clinicians should facilitate an iterative process that they revisit during routine check-ups. Therefore, successful practitioners ground these discussions in trusting relationships and include family networks to ensure a holistic approach. Key markers for initiating these talks include functional decline, escalating support needs, and frequent hospital admissions.
In India, the legal landscape for Advance Medical Directives (AMDs) has evolved significantly to support patient autonomy. Specifically, the Supreme Court's 2023 amendments simplified the execution process by replacing judicial magistrate approval with a streamlined medical board system. Furthermore, Indian experts have proposed a practical 12-step framework to help clinicians implement these plans effectively. Consequently, this pathway emphasizes the creation of "Living Wills" and the appointment of surrogate decision-makers within a culturally sensitive environment.
Clinicians should initiate these discussions early, ideally when the patient is clinically stable. Furthermore, routine triggers like transitions to home care or significant changes in functional status serve as appropriate windows for these talks.
Yes, following the 2018 Supreme Court judgment and the 2023 simplified amendments, Living Wills are legally binding. They ensure that a patient's preferences regarding life-sustaining treatment are respected by medical boards and practitioners.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical or legal advice. Refer to the latest local and national guidelines for clinical practice.
References
Simpson G et al. Advance care planning for patients with advanced multiple long-term conditions: a qualitative thematic analysis of health and social care professionals' perspectives. BMC Palliat Care. 2026 Jun 04. doi: 10.1186/s12904-026-02173-2. PMID: 42243823.
Khanna U, Khanna S. Living Will and Advance Care Planning: The Need of the Hour. J Assoc Physicians India 2025;73(12):13-14.
Damani A, Ghoshal A, Rao K, Nair S, Gursahani R, Simha S, Mani RK, Salins N. Enhancing Advance Care Planning in India through a 12-step Pathway. Indian J Crit Care Med 2025; 29 (4):301-307. DOI: 10.5005/jp-journals-10071-24938.

Explore challenges and best practices in advance care planning for patients with multiple long-term conditions, including 2023 India legal updates....
Today

A study on the BIB-Pro platform demonstrates how clinical decision support systems improve the identification of psychosocial risks during pregnancy....
Today

A review of functional hydrogels for cardiovascular therapy, covering preparation, regenerative applications, and current hurdles in clinical translation....
Today

Recent research highlights the potential of plant-derived compounds to combat dexamethasone-induced muscle atrophy by targeting the FoxO transcription facto...
Today

A study reveals that patients with active mucormycosis exhibit significantly reduced natural killer cell counts, indicating a distinct immunologic phenotype...
Today